CIK: 0001825034 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $369,451 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VTV | VANGUARD INDEX FDS | 520,000 | $99,315 | 26.9% | $190.99 | — | VALUE ETF | 922908744 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VEU | VANGUARD INTL EQUITY INDEX F | 2,990,084 (+16.0%) | $219,951 (+19.5%) | 59.5% | $64.18 | — | ALLWRLD EX US | 922042775 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORIC | ORIC PHARMACEUTICALS INC | 989,410 | $8,093 | 2.2% | $23.68 | -51.4% | COM | 68622P109 |
| ALEC | ALECTOR INC | 1,307,858 | $2,040 | 0.6% | $10.94 | -83.8% | COM | 014442107 |
| TNYA | TENAYA THERAPEUTICS INC | 1,015,705 | $723 | 0.2% | $19.78 | -93.1% | COM | 87990A106 |
| SRZN | SURROZEN INC | 87,696 | $1,982 | 0.5% | $6.97 | +132.0% | COM NEW | 86889P208 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,573,761 | $8,498 | 2.3% | $16.74 | -72.9% | COM | 344174107 |
| INDA | ISHARES TR | 369,600 | $19,977 | 5.4% | $42.12 | — | MSCI INDIA ETF | 46429B598 |
| RAPT | RAPT THERAPEUTICS INC | 82,234 | $2,785 | 0.8% | $7.63 | +307.1% | COM NEW | 75382E208 |
| PMVP | PMV PHARMACEUTICALS INC | 2,627,643 | $3,285 | 0.9% | $35.52 | -96.2% | COM | 69353Y103 |
| SPY | SPDR S&P 500 ETF TR | 4,104 | $2,799 | 0.8% | $485.48 | — | TR UNIT | 78462F103 |
| SRZNW | SURROZEN INC | 170,833 | $3 | 0.0% | $0.04 | — | *W EXP 08/01/203 | 86889P117 |